Halozyme Therapeutics

HALO | NASDAQ | 1 Obserwujący

$57.15

-0.83%

-$0.48

Obserwuj

Overview Metrics Financials

Fair Price

$02.59

Undervalued by 54.9%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Halozyme Therapeutics, Inc. is a U.S.-based biotechnology company focused on developing innovative therapeutic agents and technologies that improve drug absorption. Founded in 1998 and headquartered in San Diego, California, Halozyme is best known for its Enhanze™ platform, which uses enzymes to accelerate the absorption of biologic drugs, enabling them to be administered in lower doses or over shorter periods. The company collaborates with numerous pharmaceutical and biotechnology firms to develop new therapeutic products.

Feed

There are no posts to show right now.

Halozyme Therapeutics

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?